Basic Information
Correlia Biosystems was originally a research project under the Herr Lab bioengineering laboratory at the University of California, Berkeley. The company is now developing a new generation of proteomics technology, integrating complex assay methods such as ELISA or other immunoassays into a rapid, automated, and portable platform for pharmaceutical and diagnostic purposes. The company provides medical researchers with a proteomics database aimed at reducing the time and labor costs associated with protein assays.
Correlia Biosystems, Inc.
Berkeley,California,United States of America
less than 15 people
June 01, 2013
info@correliabio.com

